Levamisole in a phase I trial.
D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007978:Levamisole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy*
D007978:Levamisole